StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.26−0.11 (-8.03%)

Close on Nov 19, 2026Market cap $2.31MP/E –Yield –

NeuroSense Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$7.67M. The highest annual figure on record is -$582.00K in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.67M–
FY2024Dec 31, 2024-$10.14M–
FY2023Dec 31, 2023-$8.35M–
FY2022Dec 31, 2022-$7.62M–
FY2021Dec 31, 2021-$1.54M–
FY2020Dec 31, 2020-$695.00K–
FY2019Dec 31, 2019-$582.00K–

More NeuroSense Therapeutics figures

See a number that looks wrong?